Under the deal, Tilray and Sandoz will supply nonsmokable and noncombustible medical cannabis products where they are legal. In addition, the two companies may co-brand certain products and develop new ones.
“This agreement represents a major milestone in the movement to provide access to safe, GMP-certified medical cannabis to patients in need across the world,” said Tilray CEO Brendan Kennedy.
The agreement marks the first of its kind for medical marijuana and a major milestone for the pharma industry, STAT reports.
More articles on pharmacy:
Pharmaceutical company files for bankruptcy, receives $200M takeover bid
Merck’s global human health president to step down, advise CEO
Kroger launches discount program for out-of-pocket prescription drugs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
